A comment to improve tumor-treating fields therapy

被引:0
|
作者
Fioranelli, Massimo [1 ]
Sepehri, Alireza [1 ]
机构
[1] Ist Terapie Sistem Integrate, Via Flaminia 499, I-00191 Rome, Italy
来源
AIMS BIOENGINEERING | 2023年 / 10卷 / 01期
关键词
tumor; TTFields; therapy; bubble; blood;
D O I
10.3934/bioeng.2023002
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Recent investigations have shown that special frequencies and intensities of electromagnetic waves could control the differentiations of some types of cells. Using this fact, tumor-treating fields (TTFields) therapy has been proposed as a technique which uses alternating electric fields of intermediate frequency (similar to 100-500 kHz) and low intensity (1-3 V/cm) to disrupt the cell divisions of tumors. However, this technique may have harmful effects on ionic liquids around normal cells. For example, electrodes could induce an extra electrical current within blood vessels. To observe these effects, we connected electrodes to a slide that includes water and some extra ions and put them under a 1000x microscope. We found that some ions, microbes and cells move toward negative electrons and some go away. These attractions of cells by electrodes could cause the destruction of the brain. We also found some electrical currents within the liquid emerge which absorb or repel water molecules and induce some bubbles. If these types of bubbles arise within the blood vessels, they can exert a force on the membranes of normal cells and destroy them. To avoid these problems, we suggest that electrodes should be replaced by some electromagnetic sender/receiver which emits some special frequencies. These frequencies could be absorbed only by blood vessels around the tumors because these vessels may be created only to provide the needed food for tumor cells and thus have a different potential and electrical current as compared to vessels around normal cells. Thus, these tumor vessels could act as the antenna for TTFields.
引用
收藏
页码:13 / 23
页数:11
相关论文
共 50 条
  • [21] The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma
    Bernard-Arnoux, F.
    Lamure, M.
    Ducray, F.
    Aulagner, G.
    Honnorat, J.
    Armoiry, X.
    NEURO-ONCOLOGY, 2016, 18 (08) : 1129 - 1136
  • [22] Tumor-treating fields as a fourth treating modality for glioblastoma: a meta-analysis
    Dimitrios E. Magouliotis
    Eftihia K. Asprodini
    Konstantina A. Svokos
    Vasiliki S. Tasiopoulou
    Alexis A. Svokos
    Steven A. Toms
    Acta Neurochirurgica, 2018, 160 : 1167 - 1174
  • [23] Tumor-Treating Fields Answering the Concern About Quality of Life
    Halasz, Lia M.
    Mitin, Timur
    JAMA ONCOLOGY, 2018, 4 (04) : 504 - 505
  • [24] Biological activity of tumor-treating fields in preclinical glioma models
    Manuela Silginer
    Michael Weller
    Roger Stupp
    Patrick Roth
    Cell Death & Disease, 2017, 8 : e2753 - e2753
  • [25] Tumor-Treating Fields Inhibit the Metastatic Potential of Osteosarcoma Cells
    Oh, Ju Yeon
    Lee, Yeon-Joo
    Kim, Eun Ho
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2020, 19
  • [26] Living in a material world: tumor-treating fields at the top of the charts
    Schiff, David
    Schrag, Deborah
    NEURO-ONCOLOGY, 2016, 18 (08) : 1033 - 1034
  • [27] What is the Role of Tumor-treating Fields in Newly Diagnosed Glioblastoma?
    Ornelas, Abbie S.
    Porter, Alyx B.
    Sharma, Akanksha
    Knox, Molly G.
    Marks, Lisa A.
    Wingerchuk, Dean M.
    O'Carroll, Cumara B.
    NEUROLOGIST, 2019, 24 (02) : 71 - 73
  • [28] Biological activity of tumor-treating fields in preclinical glioma models
    Silginer, Manuela
    Weller, Michael
    Stupp, Roger
    Roth, Patrick
    CELL DEATH & DISEASE, 2017, 8 : e2753 - e2753
  • [29] Tumor-treating fields as a fourth treating modality for glioblastoma: a meta-analysis
    Magouliotis, Dimitrios E.
    Asprodini, Eftihia K.
    Svokos, Konstantina A.
    Tasiopoulou, Vasiliki S.
    Svokos, Alexis A.
    Toms, Steven A.
    ACTA NEUROCHIRURGICA, 2018, 160 (06) : 1167 - 1174
  • [30] IMPACT OF TUMOR-TREATING FIELDS (TTFIELDS) ON THE IMMUNOGENICITY OF GLIOMA CELLS
    Silginer, Manuela
    Weller, Michael
    Roth, Patrick
    NEURO-ONCOLOGY, 2018, 20 : 133 - 133